EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

BRCA1 levels and DNA-damage response are controlled by the competitive binding of circHIPK3 or FMRP to the BRCA1 mRNA

Chiara Grelloni, Raffaele Garraffo, Adriano Setti, Francesca Rossi, Giovanna Peruzzi, Mario Cinquanta, Maria Carmela Di Rosa, Marco Alessandro Pierotti, Manuel Beltran, Irene Bozzoni

Molecular Cell · 2024-11 · 84 (21) · 4079-4094.e10

DOI: 10.1016/j.molcel.2024.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024-11. Verfasst von Chiara Grelloni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: BRCA1 Protein, RNA, Circular, RNA, Messenger, DNA Damage. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, HORIZON EUROPE European Research Council, Ministero dell’Istruzione, dell’Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinRNA, CircularRNA, MessengerDNA DamageFragile X Messenger Ribonucleoprotein 1Protein Serine-Threonine KinasesHumansBinding, CompetitiveIntracellular Signaling Peptides and ProteinsGene Expression Regulation, NeoplasticBreast NeoplasmsRNAHEK293 CellsProtein BindingCell Line, TumorProtein BiosynthesisMCF-7 CellsFemale

Stichwörter der Autor:innen

BRCA1DNA-damage responseFMRPRNA-RNA interactionanti-cancer treatmentscircRNAstranslational regulation

Substanzen

BRCA1 ProteinRNA, CircularRNA, MessengerFragile X Messenger Ribonucleoprotein 1Protein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsRNABRCA1 protein, humanFMR1 protein, humanHIPK3 protein, human

Autor:innen und Institutionen

  • Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, 00185 Rome, Italy.
  • Center for Life Nano- & Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy.
  • Cogentech ltd Benefit C. Registered Office, 20133 Milan, Italy.
  • Local Unit c/o Scientific & Technologic Park of Sicily, 95121 Catania, Italy.
  • Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, 00185 Rome, Italy. Electronic address: manuel.beltrannebot@uniroma1.it.
  • Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, 00185 Rome, Italy; Center for Life Nano- & Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy. Electro…

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS
  • HORIZON EUROPE European Research Council
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Grelloni, C., Garraffo, R., Setti, A., Rossi, F., Peruzzi, G., Cinquanta, M., Di Rosa, M. C., Pierotti, M. A., Beltran, M., & Bozzoni, I. (2024). BRCA1 levels and DNA-damage response are controlled by the competitive binding of circHIPK3 or FMRP to the BRCA1 mRNA. Molecular Cell, 84(21), 4079-4094.e10. https://doi.org/10.1016/j.molcel.2024.09.016

Vancouver

Grelloni C, Garraffo R, Setti A, Rossi F, Peruzzi G, Cinquanta M, et al. BRCA1 levels and DNA-damage response are controlled by the competitive binding of circHIPK3 or FMRP to the BRCA1 mRNA. Molecular Cell. 2024;84(21):4079-4094.e10. doi:10.1016/j.molcel.2024.09.016

BibTeX
@article{Grelloni2024,
  author = {Grelloni, Chiara and Garraffo, Raffaele and Setti, Adriano and Rossi, Francesca and Peruzzi, Giovanna and Cinquanta, Mario and Di Rosa, Maria Carmela and Pierotti, Marco Alessandro and Beltran, Manuel and Bozzoni, Irene},
  title = {BRCA1 levels and DNA-damage response are controlled by the competitive binding of circHIPK3 or FMRP to the BRCA1 mRNA},
  journal = {Molecular Cell},
  year = {2024},
  volume = {84},
  number = {21},
  pages = {4079--4094.e10},
  doi = {10.1016/j.molcel.2024.09.016}
}
Kostenlos starten →